| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102262 For prophhylaxis of Staphylococcus aureus infection |
| 08/01/2002 | US20020102256 Peptide and polypeptide inhibitors of complement C1s |
| 08/01/2002 | US20020102252 Novel isoforms of human pregnancy-associated protein-E |
| 08/01/2002 | US20020102245 14-3-3sigma arrests the cell cycle |
| 08/01/2002 | US20020102244 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell |
| 08/01/2002 | US20020102242 Compositions and methods for administering pneumococcal DNA |
| 08/01/2002 | US20020102240 Administering therapeutically effective amount of beta 1C integrin reagent which inhibits cellular proliferation |
| 08/01/2002 | US20020102234 Contacting pure or recombinant mammalian (interleukin)IL- 1 delta or IL-L1 epsilon with a receptor comprising the IL-1R6 receptor subunit; or mammalian IL-1 delta or IL-1 epsilon with a receptor to form complex |
| 08/01/2002 | US20020102233 For use in therapy of cancer |
| 08/01/2002 | US20020102232 Compositions and methods for induction of active autoimmunity |
| 08/01/2002 | US20020102210 Treating target organism having a developing gonadal cell responsive to protein with potential modulator(s) of cell migration; observing change in migration or shape of developing gonadal cell attributable to presence of modulator |
| 08/01/2002 | DE10102977A1 Testsystem zur Entwicklung von Therapeutika, insbesondere von Wirkstoffen zur Behandlung von Osteoporose Test system for the development of therapeutics, in particular of drugs used to treat osteoporosis |
| 08/01/2002 | DE10101890A1 HPV-spezifische Peptide, die die Bindung von HPV an die Wirtszelle blockieren HPV specific peptides that block the binding of HPV to the host cell |
| 08/01/2002 | DE10101793A1 Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen Use of SLPI in the treatment of chronic inflammatory bowel disease |
| 08/01/2002 | DE10101430A1 Lösliche cyclische Analoga Soluble cyclic analogues |
| 08/01/2002 | DE10100305A1 Knorpelzellmarker, Verfahren sowie Verwendungen desselben The same chondrocyte marker, processes and uses |
| 08/01/2002 | CA2792244A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | CA2435949A1 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | CA2435910A1 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435622A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | CA2435510A1 Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2.alpha.alphaactivity and methods of treating cancer |
| 08/01/2002 | CA2435433A1 High level cytokine production with enhanced cell viability |
| 08/01/2002 | CA2435097A1 Peptides exibiting affinity for the viral protein gp120, and use of the se peptides |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434847A1 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 08/01/2002 | CA2434845A1 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | CA2434320A1 Chemokines as adjuvants of immune response |
| 08/01/2002 | CA2433869A1 Gene for identifying individuals with familial dysautonomia |
| 08/01/2002 | CA2433834A1 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | CA2433227A1 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | CA2432276A1 Regulation of cell growth by muc1 |
| 08/01/2002 | CA2432096A1 Methods for preparing purified lipopeptides |
| 08/01/2002 | CA2431522A1 Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2431177A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | CA2431144A1 Cell adhesion proteins |
| 08/01/2002 | CA2430762A1 Colon cancer marker |
| 08/01/2002 | CA2429779A1 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | CA2429343A1 Nucleic acids and polypeptides |
| 08/01/2002 | CA2428084A1 Treatment of inflammatory bowel disease using growth factors |
| 08/01/2002 | CA2427676A1 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and recombinant cell line expressing a human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 08/01/2002 | CA2427061A1 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | CA2426154A1 Agents and methods for promoting bone growth |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 08/01/2002 | CA2425794A1 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 08/01/2002 | CA2425506A1 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 08/01/2002 | CA2425149A1 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents |
| 07/31/2002 | EP1227324A2 Har A polypeptides and nucleic acids and related methods and uses thereof |
| 07/31/2002 | EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines |
| 07/31/2002 | EP1227321A1 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 07/31/2002 | EP1227156A2 A human protein kinase domain-containing protein |
| 07/31/2002 | EP1227154A2 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 07/31/2002 | EP1227153A2 Serpin from Bifidobacteria |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1227151A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 07/31/2002 | EP1227150A2 Androgen receptor complex-associated protein |
| 07/31/2002 | EP1227149A1 Novel protein and use thereof |
| 07/31/2002 | EP1227148A1 Gene ys68 concerning early hematopoiesis |
| 07/31/2002 | EP1227107A1 Selective acylation of E-amino groups |
| 07/31/2002 | EP1227106A1 Pro-apoptotic proteins and DNA molecules encoding them |
| 07/31/2002 | EP1227105A1 Ghsr ligand polypeptides and dnas thereof |
| 07/31/2002 | EP1226752A1 Transgenic non-human mammals for monitoring change in calcium ion concentration in cells |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226280A2 Genetic sequences associated with neural cell proliferation and disease |
| 07/31/2002 | EP1226279A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 07/31/2002 | EP1226278A1 Methods for identifying and using maintenance genes |
| 07/31/2002 | EP1226276A2 Diagnostic test for cephalic pain |
| 07/31/2002 | EP1226266A2 Method for enhancing secretion of beta-lactam compounds |
| 07/31/2002 | EP1226264A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/31/2002 | EP1226261A2 Seed-preferred promoter from barley |
| 07/31/2002 | EP1226259A1 Isolation and characterization of a fiber-specific actin promoter from cotton |
| 07/31/2002 | EP1226258A1 Cell surface display of proteins by recombinant host cells |
| 07/31/2002 | EP1226256A1 Recombinant therapeutic fusion proteins |
| 07/31/2002 | EP1226254A2 Virulence genes, proteins, and their use |
| 07/31/2002 | EP1226253A2 Neisserial antigenic peptides |
| 07/31/2002 | EP1226252A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226251A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 07/31/2002 | EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 07/31/2002 | EP1226242A1 Human cub-domain-containing protein and gene encoding the same |
| 07/31/2002 | EP1226241A1 A general method for optimizing the expression of heterologous proteins |
| 07/31/2002 | EP1226240A2 Spf1-related transcription factors |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226178A1 Recombinant fusion molecules |
| 07/31/2002 | EP1226177A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/31/2002 | EP1226175A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226174A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |